Skip to content
lifestyle.capitolhilltimes.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Polaryx Therapeutics, Inc.
Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium™
February 12, 2026
Polaryx Therapeutics Welcomes New Members of the Board of Directors
February 11, 2026
Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium™ as Company Prepares for SOTERIA Trial Launch
February 3, 2026
Polaryx Therapeutics Announces Direct Listing on Nasdaq; Shares to Begin Trading Under the Symbol “PLYX”
February 2, 2026
Polaryx Therapeutics Announces Approval to List Common Stock on Nasdaq
January 30, 2026
←
Previous Page
1
2